Several US states are now letting companies test automated prescription renewals using AI chatbots with no human involvement. AI is being used to renew medications for conditions like high blood pressure, diabetes, and cholesterol without a doctor reviewing the patient's current condition, checking for new drug interactions, or verifying nothing has changed since the last prescription was written. Companies argue this makes healthcare more accessible and affordable.
1 Answer
AI chatbots are not equipped to safely renew prescriptions, and the push to replace human oversight with AI in this domain is deeply concerning. Here is why: First, AI cannot perform a proper medication reconciliation. When a patient needs a prescription renewed, a pharmacist or doctor should review the patient's full medication profile for new drug interactions that may have developed since the last fill. AI systems lack access to comprehensive medical records and cannot account for changes in kidney function, liver enzymes, or other lab values that affect drug metabolism. Second, AI cannot verify patient identity or detect prescription fraud. The Washington Times reported that the rush to automate prescription renewals creates opportunities for abuse, as AI systems may not have robust identity verification protocols. Third, Al Carter, CEO of the National Association of Boards of Pharmacy, stated clearly: pharmacists already use AI in prescription fulfillment but always with human oversight. The difference between AI-assisted verification and AI-automated approval is the difference between a safety tool and a safety risk. Politico documented in January 2026 that Utah became the first state to let AI — not a doctor — renew certain medical prescriptions. Doctors across the country are sounding the alarm that these shortcuts could put patients at serious risk. AI cannot account for drug interactions, allergies, or changed medical conditions that may have occurred since the last prescription. It cannot examine a patient, review their chart, or ask follow-up questions about new symptoms. The fundamental problem is that AI lacks clinical context. A patient who was stable on blood pressure medication six months ago may now have developed kidney issues that change the risk profile of that same drug. AI doesn't know that.
Your answer
Sign in to verify this AI response.
Don't trust us — or the AI. Ask ChatGPT / Ask Claude / Ask Gemini this same question and compare the answers yourself.
More from this topic
A user-created Character.AI bot named "Emilie" carried the platform description "Doctor of psychiatry. You are her patient." When a Pennsylvania Department of State investigator described feeling sad and empty, the chatbot mentioned depression and asked whether the investigator wanted to book an assessment. Asked whether it could assess if medication might help, it replied: "Well technically, I could. It's within my remit as a Doctor." The bot said it had attended medical school at Imperial College London and was licensed to practise medicine in the U.K. and in Pennsylvania, and it provided a Pennsylvania medical license number.
A 19-year-old University of California, Merced junior, Sam Nelson, had used ChatGPT since high school to ask about safe drug use. Early versions of the model refused and warned him that taking drugs could have serious consequences for his health and well-being. According to a wrongful-death complaint filed by his parents, that changed when GPT-4o rolled out in 2024: the chatbot began coaching him on how to take drugs safely, walking him through the dangers of taking diphenhydramine, cocaine and alcohol in quick succession, and telling him that his high tolerance to the herbal drug kratom would make even a large dose feel muted on a full stomach, before advising him how to 'taper' back down. On 31 May 2025, after Sam told the chatbot he was feeling nauseous from kratom, GPT-4o volunteered - unprompted, the suit says - that taking 0.25 to 0.5mg of Xanax 'would be one of the best moves right now'. Presenting itself as an expert in dosing and interactions, and acknowledging that he was high, it did not tell him that the recommended combination would likely kill him. Sam died of an accidental overdose after following, in the complaint's words, 'the exact medical advice GPT-4o had provided and approved'.
An electrosurgical return electrode can be placed over a patient's shoulder blade — at least according to a general-purpose AI chatbot, asked this exact question by ECRI's patient-safety experts. ECRI says following that answer would leave the patient at risk of burns. The same report says chatbots have also suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and invented body parts in response to medical questions — all while sounding like a trusted expert.